| |
| |
|
| Insider
Information: |
Baker Bros. Investments, L.p. |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
339,110 |
|
|
Indirect Shares
|
8,040,326 |
|
|
| Direct
Value |
$11,032,026 |
|
|
|
Indirect Value
|
$496,729,552 |
|
|
| Total
Shares |
8,379,436 |
|
|
| Total
Value |
$507,761,577 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synageva BioPharma Corp |
GEVA |
Director |
2012-07-13 |
165,213 |
|
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-07-26 |
173,897 |
2019-06-14 |
7,815,145 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2013-08-01 |
0 |
2013-08-01 |
225,181 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GHDX |
Genomic Health Inc |
Director |
– • • |
2019-06-14 |
4 |
A |
$0.00 |
$0 |
I/I |
11,460 |
7,641,248 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2019-04-01 |
4 |
A |
$66.84 |
$119,510 |
I/I |
1,788 |
8,412,478 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-11-13 |
4 |
S |
$78.09 |
$10,889,359 |
I/I |
(138,712) |
10,839,295 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2018-11-12 |
4 |
S |
$80.51 |
$5,317,265 |
I/I |
(65,588) |
10,953,589 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2016-09-30 |
4 |
A |
$28.92 |
$119,729 |
I/I |
4,140 |
319,313 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2016-08-15 |
4 |
B |
$27.02 |
$2,701,590 |
I/I |
100,000 |
11,348,958 |
2.25 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2016-07-01 |
4 |
A |
$26.74 |
$119,688 |
I/I |
4,476 |
318,623 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
– – • |
2013-08-01 |
4 |
B |
$4.40 |
$5,000,002 |
I/I |
1,136,364 |
145,533 |
1.5 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2012-07-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
173,897 |
|
- |
|
| GEVA |
Synageva BioPharma Corp |
Director |
– • – |
2012-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
165,213 |
|
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
